Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 1, 2009, Pages 192-194

  Reyes, Guillermo ^a   Allen, Keith B ^b   Aguado, Beatriz ^a   Duarte, Juan ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

Angiogenesis; Laser; Stem cells; Transmyocardial revascularisation

Indexed keywords

ALUMINUM; CD133 ANTIGEN; CD34 ANTIGEN; HOLMIUM; YTTRIUM;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW LASER REVASCULARIZATION; CENTRIFUGATION; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; ILIAC CREST; MALE; MONONUCLEAR CELL; NEEDLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL; TREATMENT RESPONSE;

AGED; ANGINA PECTORIS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349287853     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.03.022     Document Type: Article

References (8)

1. Muhkerjee D., Bhatt D., Roe T., Patel V., and Ellis S.G. Direct myocardial revascularization and angiogenesis: how many patients might be eligible?. Am J Cardiol 84 5 (1999) 598-600
2. Cheng D., Diegeler A., Allen K., Weisel R., Lutter G., Sartori M., Asai T., Aaberge L., Horvath K., and Martin J. Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials. Innovations 1 (2006) 295-313
3. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Mayysky M., Ashare A.B., Lathi K., and Isner J.M. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98 25 (1998) 2800-2804
4. + stem cells in patients with refractory ischemia: preliminary results. Thorac Cardiovasc Surg 56 2 (2008) 71-76
5. Lutter G., Attmann T., Heilmann C., von Samson P., von Specht B., and Beyersdorf F. The combined use of transmyocardial laser revascularization (TLMR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. Eur J Cardiothorac Surg 22 5 (2002) 753-761
6. Patel A.N., Spadaccio C., Kuzman M., Park E., Fischer D.W., Stice S.L., Mullangi C., and Toma C. Improved cell survival in infarcted myocardium using novel combination transmyocardial laser and cell delivery system. Cell Transplant 16 9 (2007) 899-905
7. Klein H.M., Ghodsizad A., Borowski A., Saleh A., Draganov J., Poll L., Stoldt V., Feifel N., Piecharkczek C., Burchardt E.R., Stocksclader M., and Gams E. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for patients with end-stage coronary heart disease: report on 2 cases. Heart Surg Forum 7 5 (2004) E416-E419
8. Gowdak L.H., Schettert I.T., Rochitte C.E., Lisboa L.A., Dallan L.A., César L.A., Krieger J.E., Ramires J.A., and Oliveira S.A. Cell therapy plus transmyocardial laser revascularization for refractory angina. Ann Thorac Surg 80 2 (2005) 712-714